Henry Ford Health
Approved Hospital Formulary
FormWeb QuickStart
Questions or Suggestions?
Pharmacy Intranet
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Biosimilar
Black Box Warning
Do Not Crush
Hazardous Drugs
Look Alike Sound Alike
Policy
REMS
Restricted Antimicrobials
Therapeutic Interchange
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
Boards
Brand name products with an equivalent generic may not be available to order at Henry Ford Health. For questions, contact inpatient pharmacy.
Henry Ford Health
Approved Hospital Formulary
FormWeb QuickStart
Questions or Suggestions?
Pharmacy Intranet
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Biosimilar
Black Box Warning
Do Not Crush
Hazardous Drugs
Look Alike Sound Alike
Policy
REMS
Restricted Antimicrobials
Therapeutic Interchange
Webpage Links
Search results for:
inFLIXimab
inFLIXimab
Drug Name
Form
Strength
Clinic Use Only
Inpatient Restrictions
Outpatient Restrictions
Non-Formulary
Inflectra
POWDER FOR INJECTION, INTRAVENOUS
dyyb 100 mg
Renflexis
POWDER FOR INJECTION, INTRAVENOUS
abda 100 mg
Remicade
POWDER FOR INJECTION, INTRAVENOUS
100 mg
VIEW MORE
immunosuppressive agents
,
miscellaneous agents
,
antirheumatics
,
immunologic agents
,
TNF alpha inhibitors
CLASS
m00104
,
m00105
,
m00192
,
m00254
,
m00442
Generic Name
Brand Name
Biosimilar (HFH preferred)
infliximab-dyyb
Inflectra
Biosimilar (approved alternate)
infliximab-abda
Renflexis
Originator product
infliximab
Remicade
Last updated:
Mar. 8, 2024
Biosimilar
Tier 1: Use of Biosimilars at Henry Ford Health System
Black Box Warning
Serious infection risk; hepatosplenic t-cell lymphomas; malignancy
Policy
Tier 1: Inpatient Infliximab Infusion Policy
Micromedex
Clinical Pharmacology
FDA DailyMed